Latest Mitral regurgitation Stories
Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver,
Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com.
NASDAQ: NVCN TSX: NVC VANCOUVER, July 7, 2014 /PRNewswire/ - Neovasc Inc.
Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path TEL AVIV, Israel, June 11, 2014 /PRNewswire/ --
PinnacleHealth Among Top Hospitals in United States to Offer Breakthrough Device for Patients with Mitral Valve Disease HARRISBURG, Pa., May 27, 2014 /PRNewswire/ --
Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver,
Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/
ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc.
Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc.
- Harpoon Has Raised More Than $300,000 in Competitive Grants and Award Funding in Less Than a Year - BALTIMORE, Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.